SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001636050-22-000035
Filing Date
2022-06-14
Accepted
2022-06-14 07:00:56
Documents
76
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-K siox-20220331.htm   iXBRL 10-K 1589105
2 EX-10.13 siox3312210kex-1013.htm EX-10.13 83522
3 EX-10.14 siox3312210kex-1014.htm EX-10.14 103264
4 EX-21.1 siox3312210kex-211.htm EX-21.1 4030
5 EX-23.1 siox3312210kex-231.htm EX-23.1 4581
6 EX-31.1 siox3312210kex-311.htm EX-31.1 11054
7 EX-32.1 siox3312210kex-321.htm EX-32.1 6847
  Complete submission text file 0001636050-22-000035.txt   6801545

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT siox-20220331.xsd EX-101.SCH 42887
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT siox-20220331_cal.xml EX-101.CAL 68136
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT siox-20220331_def.xml EX-101.DEF 170950
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT siox-20220331_lab.xml EX-101.LAB 615288
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT siox-20220331_pre.xml EX-101.PRE 377890
70 EXTRACTED XBRL INSTANCE DOCUMENT siox-20220331_htm.xml XML 898667
Mailing Address 130 WEST 42ND STREET 26TH FLOOR NEW YORK NY 10036
Business Address 130 WEST 42ND STREET 26TH FLOOR NEW YORK NY 10036 877-746-4891
Sio Gene Therapies Inc. (Filer) CIK: 0001636050 (see all company filings)

IRS No.: 853863315 | Fiscal Year End: 0331
Type: 10-K | Act: 34 | File No.: 001-37418 | Film No.: 221013415
SIC: 2834 Pharmaceutical Preparations